Keryx Biopharmaceuticals Balance Sheet
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Assets | Dec 07 | Dec 06 | Dec 05 |
|---|---|---|---|
| Current Assets | |||
| Cash | 62.1 | 112.4 | 86.4 |
| Net Receivables | 0.3 | 2.6 | 3.5 |
| Inventories | -- | -- | -- |
| Other Current Assets | 1.3 | -- | -- |
| Total Current Assets | 63.7 | 115.0 | 90.0 |
| Net Fixed Assets | 11.5 | 8.5 | 1.0 |
| Other Noncurrent Assets | 6.2 | 17.3 | 14.1 |
| Total Assets | 81.1 | 140.3 | 105.1 |
| Liabilities and Shareholder's Equity | Dec 07 | Dec 06 | Dec 05 |
| Current Liabilities | |||
| Accounts Payable | 20.4 | 12.0 | 6.0 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 1.0 | 0.2 | 0.1 |
| Total Current Liabilities | 21.4 | 12.2 | 6.1 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 15.2 | 4.3 | 4.3 |
| Total Liabilities | 36.6 | 16.5 | 10.4 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 44.4 | 123.8 | 94.7 |
| Total Equity | 44.4 | 123.8 | 94.7 |
| Shares Outstanding (mil.) | 43.7 | 43.5 | 38.0 |
This data is provided as per license from EDGAR Online
